|
US2021062220A1
|
|
Methods and constructs for production of lentiviral vector
|
|
WO2021034581A1
|
|
Cartridge with mixing zone for endotoxin detection
|
|
WO2021011547A1
|
|
Process control systems for automated cell engineering systems
|
|
US2020255793A1
|
|
Cell concentration methods and devices for use in automated bioreactors
|
|
US2020208121A1
|
|
Automated production of viral vectors
|
|
US2020199627A1
|
|
Adeno-associated virus (aav) producer cell line and related methods
|
|
US2020179582A1
|
|
Bedside automated cell engineering system and methods
|
|
WO2020123655A1
|
|
Cell isolation for use in automated bioreactors
|
|
KR20200019739A
|
|
Endotoxin Detection Cartridge
|
|
KR20190104407A
|
|
Formulation for Passage and Harvest of Single Cell Human Pluripotent Stem Cells
|
|
EP3552021A1
|
|
Coagulogen-free clarified limulus amebocyte lysate
|
|
SG11201900767VA
|
|
Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen
|
|
KR20180105670A
|
|
Methods and vectors for producing vector-free inducible pluripotent stem cells
|
|
WO2016201399A1
|
|
Methods for nuclear reprogramming using synthetic transcription factors
|
|
US2016249602A1
|
|
Method for pooling hepatocytes
|
|
US2015037882A1
|
|
Scalable process for therapeutic cell concentration and residual clearance
|
|
US2013164234A1
|
|
Composition for treating skin pigmentation
|
|
US2014272977A1
|
|
Molecular targets and methods for formulation screening and preservative efficacy testing
|
|
WO2012166755A1
|
|
Enzyme-linked immunosorbent assay for quantitation of residual trypsin in a biological sample
|
|
SG194967A1
|
|
Passaging and harvesting formulation and method for human pluripotent stem cells
|
